Cochrane · systematic review · CD006931

Submacular surgery for choroidal neovascularisation secondary to age‐related macular degeneration

Giansanti, F, Eandi, CM, Virgili, G · Cochrane Database of Systematic Reviews · 2009 · Cochrane Library

Eyes and VisionAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 2 · 28.6%Moderate 1 · 14.3%High 4 · 57.1%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Comparison

Population: patients with choroidal neovascularisation secondary to age‐related macular degeneration
7 questions
OutcomeEffectEvidenceStatus / GRADE
Visual loss of 2+ lines at 1 year
RR 0.96 [0.84, 1.09]2 studies · 715 participantsHigh
Visual gain of 2+ lines at 1 year
RR 1.06 [0.75, 1.5]2 studies · 715 participantsLow
Contrast threshold loss ‐0.15 log units or more at 1 year
RR 0.8 [0.63, 1.02]2 studies · 689 participantsModerate
Reading speed 40 word/minute or more after 1 year
RR 0.88 [0.64, 1.2]2 studies · 692 participantsHigh
Loss of 6+ points of overall NEI‐VFQ score at 1 year
RR 1.35 [1.09, 1.68]2 studies · 689 participantsLow
Downgraded: risk of bias
Adverse events: cataract surgery at 1 year
RR 8.69 [4.06, 18.61]2 studies · 632 participantsHigh
Adverse events: retinal detachment during
RR 6.13 [2.81, 13.38]2 studies · 790 participantsHigh